πŸ‡ΊπŸ‡Έ FDA
Patent

US 10350296

Chewable gelatin formulations

granted A61KA61K47/42A61K9/0056

Quick answer

US patent 10350296 (Chewable gelatin formulations) held by Aspire Pharmaceuticals expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aspire Pharmaceuticals
Grant date
Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K47/42, A61K9/0056